microPublication Biology adheres to the highest standards for publication ethics, transparency and data FAIRness. Specifically, microPublication Biology conforms to the Minimum Information Standards for scientific data reporting (MIBBI), follows the guidelines of the Committee on Publication Ethics (COPE), adheres -- as far as possible given the novel publication platform-- with recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals and follows the FAIR (findable, accessible, interoperable and reproducible) data principles (Wilkinson et al., 2016). microPublication Biology will use the deep curatorial expertise of these organizations to ensure that federal funding mandates for FAIR principles in data management are adhered to, aiding researchers in complying with their funding bodies in a trackable and persistent manner.
Open access license for microPublication Biology
Each microPublication is an open-access article distributed under the terms of the Creative Commons Attribution License.
Conflicts of interest
microPublication Biology adheres to the Committee on Publication Ethics (COPE) guidelines on conflicts of interest. Authors, reviewers and editors are required to declare any conflicts of interests that could be perceived as affecting the objectivity of presenting, reviewing or handling of the work.
microPublication Biology follows the authorship guidelines of the International Committee of Medical Journal Editors (ICMJE). All authors share responsibility for the content of the microPublication. Authorship should be limited to those persons that performed the experiment, any analysis, and or write-up. Individuals who do not satisfy authorship guidelines but participated materially in the work, should be included in the acknowledgement section.
In the near future we will use CRediT (Contributor Roles Taxonomy) to define author's contributions. CRediT will be used to represent the diverse roles of contributors to the scientific scholarly output. CRediT aims to provide transparency to the contributions of researchers to scholarly published work, to enable discoverability and to improve attribution, credit, and accountability.
The PI of the laboratory in which the work was performed may or may not be included at the discretion of the PI; however this PI must approve the submission of the article and provide the details of any funding source.
Authors are required to accept the following conditions when submitting an article:
"I/we declare to the best of my/our knowledge that the experiment is reproducible; that the submission has been approved by all authors; that the submission has been approved by the laboratory's Principal Investigator, and that the results have not been published elsewhere by us. The author(s) declare no conflict of interest."
If microPublication Biology receives an allegation of possible research or publication misconduct, affected individuals will be contacted for a response. microPublication Biology follows the COPE (Committee on Publication Ethics) guidelines on scientific misconduct. microPublication Biology reserves the right to (a) terminate the review process; (b) take the appropriate steps to correct the scientific record; and (c) contact employer, institution or funding agency/regulatory body to investigate.
microPublication Biology does not consider unintentional mistakes (e.g., incorrect author list, incorrect strain name, etc.) to be misconduct. In this case, the small change will be fixed and published as a Corrigendum.
In the future, at the time of submission, microPublication Biology manuscripts will be scanned with text and image plagiarism software.
The funding agency or source must be indicated in the appropriate submission field.
Data and reagents
It is the expectation that published data and reagents will be made freely available, in a timely manner, upon request. In addition, all data will be made available for reuse on public, open-access, community knowledgebases.
In the case of a microPublication providing results that support the scientific validity of a commercial commodity (e.g., engineered strain, apparatus, etc.), then the article is indicated as a “Commodity validation”.